Differentiated tumors proliferate more slowly and express more surface molecules like major histocompatibility complex-class I (MHC-I), CD54, and PD-L1, improving immune recognition and reducing tumor-supportive microenvironments [59,101]. The gene discussed is ICAM1; the disease is neoplasm.